Date Initiated by Firm |
January 19, 2009 |
Date Posted |
May 25, 2012 |
Recall Status1 |
Terminated 3 on September 12, 2012 |
Recall Number |
Z-1436-2012 |
Recall Event ID |
52013 |
Product Classification |
Medical computers and software - Product Code LNX
|
Product |
Abacus TPN Calculating Software
Product Usage: LIMS Windows-based program for order entry and TPN calculation.
|
Code Information |
Catalogue Numbers: 8300-0045: Abacus Calculator Only (Abacus CE) 8300-0046: Abacus Single Work Station (Abacus SE) 8300-0047: Abacus Multi-Work Station (Abacus ME) |
Recalling Firm/ Manufacturer |
Baxa Corporation 14445 Grasslands Dr Englewood CO 80112
|
For Additional Information Contact |
Anne Szilagyi 800-678-2292
|
Manufacturer Reason for Recall |
Ordering salt-based ingredients on an ion-based template resulted in medication errors when calculating amounts of ingredients required.
|
FDA Determined Cause 2 |
Labeling design |
Action |
Baxa Corporation sent a "Safety Alert" letter dated January 19, 2009 via FedEx to all affected customers. The letter described the affected product, problem, and actions to be taken. Customers were instructed to ensure that users create either a salt-based template OR an ion-based template for ordering, and that both methods of ordering are not used in one template. Customers were provided a list of safe practices to follow on the enclosed ISMP Safety Alert. Customers were advised upon receipt of the Safety Alert that Baxa Technical Support will review and address any issues with the customer on their configuration setup for calcium and magnesium. For questions contact Baxa Technical Support at 1-800-678-2292. |
Quantity in Commerce |
667 units |
Distribution |
Worldwide Distribution - US (Nationwide) and the countries of: Canada, China, Australia, Panama and Columbia. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|